Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage

被引:264
作者
Goldstein, J. N.
Fazen, L. E.
Snider, R.
Schwab, K.
Greenberg, S. M.
Smith, E. E.
Lev, M. H.
Rosand, J.
机构
[1] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA
关键词
D O I
10.1212/01.wnl.0000257087.22852.21
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Patients with acute intracerebral hemorrhage ( ICH) presenting within 3 hours of symptom onset are known to be at increased risk of expansion. However, only a minority arrive within this time frame. Therefore, alternative markers for expansion risk are needed. Objective: To examine whether contrast extravasation on CT angiography ( CTA) at presentation predicts subsequent hematoma expansion. Methods: Consecutive patients with primary ICH presenting to an urban tertiary care hospital were prospectively captured in a database. We retrospectively reviewed images for all patients receiving a CTA and at least one further CT scan within 48 hours. Results: Complete data were available for 104 patients. Contrast extravasation at the time of CTA was present in 56% of patients, and associated with an increased risk of hematoma expansion ( 22% vs 2%, p = 0.003). Patients who received a baseline CTA within 3 hours were more likely to have subsequent expansion ( 27%, vs 13% for those presenting later, p = 0.1). However, after multivariable analysis, contrast extravasation was the only significant predictor of hematoma expansion ( OR 18, 95% CI 2.1 to 162). This effect was independent of time to presentation. Conclusions: Contrast extravasation is independently associated with hematoma expansion. Patients presenting within the first few hours after symptom onset have traditionally been considered those at highest risk of expansion. However, for those presenting later, the presence of contrast may be a useful marker to guide therapies aimed at decreasing this risk.
引用
收藏
页码:889 / 894
页数:6
相关论文
共 29 条
  • [1] Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage
    Becker, KJ
    Baxter, AB
    Bybee, HM
    Tirschwell, DL
    Abouelsaad, T
    [J]. STROKE, 1999, 30 (10) : 2025 - 2032
  • [2] Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage
    Brody, DL
    Aiyagari, V
    Shackleford, AM
    Diringer, MN
    [J]. NEUROCRITICAL CARE, 2005, 2 (03) : 263 - 267
  • [3] Early hemorrhage growth in patients with intracerebral hemorrhage
    Brott, T
    Broderick, J
    Kothari, R
    Barsan, W
    Tomsick, T
    Sauerbeck, L
    Spilker, J
    Duldner, J
    Khoury, J
    [J]. STROKE, 1997, 28 (01) : 1 - 5
  • [4] Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
    Davis, SM
    Broderick, J
    Hennerici, M
    Brun, NC
    Diringer, MN
    Mayer, SA
    Begtrup, K
    Steiner, T
    [J]. NEUROLOGY, 2006, 66 (08) : 1175 - 1181
  • [5] Deveras RAE, 2002, ANN INTERN MED, V137, P884, DOI 10.7326/0003-4819-137-11-200212030-00009
  • [6] Potential applicability of recombinant factor VIIa for intracerebral hemorrhage
    Flaherty, ML
    Woo, D
    Haverbusch, M
    Moomaw, CJ
    Sekar, P
    Sauerbeck, L
    Kissela, B
    Kleindorfer, D
    Broderick, JP
    [J]. STROKE, 2005, 36 (12) : 2660 - 2664
  • [7] Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
    Flibotte, JJ
    Hagan, N
    O'Donnell, J
    Greenberg, SM
    Rosand, J
    [J]. NEUROLOGY, 2004, 63 (06) : 1059 - 1064
  • [8] Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage
    Fujii, Y
    Takeuchi, S
    Sasaki, O
    Minakawa, T
    Tanaka, R
    [J]. STROKE, 1998, 29 (06) : 1160 - 1166
  • [9] Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage
    Goldstein, JN
    Thomas, SH
    Frontiero, V
    Joseph, A
    Engel, C
    Snider, R
    Smith, EE
    Greenberg, SM
    Rosand, J
    [J]. STROKE, 2006, 37 (01) : 151 - 155
  • [10] The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase
    Hacke, W
    Albers, G
    Al-Rawi, Y
    Bogousslavsky, J
    Davalos, A
    Eliasziw, M
    Fischer, M
    Furlan, A
    Kaste, M
    Lees, KR
    Soehngen, M
    Warach, S
    [J]. STROKE, 2005, 36 (01) : 66 - 73